25 XP   0   0   10

Koninklijke Philips NV
Buy, Hold or Sell?

Let's analyse Philips together

PenkeI guess you are interested in Koninklijke Philips NV. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Koninklijke Philips NV. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Koninklijke Philips NV

I send you an email if I find something interesting about Koninklijke Philips NV.

Quick analysis of Philips (30 sec.)










What can you expect buying and holding a share of Philips? (30 sec.)

How much money do you get?

How much money do you get?
€0.01
When do you have the money?
1 year
How often do you get paid?
100.0%

What is your share worth?

Current worth
€13.31
Expected worth in 1 year
€7.91
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
€-5.38
Return On Investment
-28.5%

For what price can you sell your share?

Current Price per Share
€18.90
Expected price per share
€18.09 - €22.18
How sure are you?
50%

1. Valuation of Philips (5 min.)




Live pricePrice per Share (EOD)

€18.90

Intrinsic Value Per Share

€0.29 - €14.30

Total Value Per Share

€13.60 - €27.60

2. Growth of Philips (5 min.)




Is Philips growing?

Current yearPrevious yearGrowGrow %
How rich?$12.8b$14.1b-$1.3b-10.1%

How much money is Philips making?

Current yearPrevious yearGrowGrow %
Making money-$496.1m-$1.7b$1.2b247.2%
Net Profit Margin-2.6%-9.1%--

How much money comes from the company's main activities?

3. Financial Health of Philips (5 min.)




4. Comparing to competitors in the Medical Devices industry (5 min.)




  Industry Rankings (Medical Devices)  


Richest
#7 / 339

Most Revenue
#1 / 339

Most Profit
#338 / 339

Most Efficient
#142 / 339

What can you expect buying and holding a share of Philips? (5 min.)

Welcome investor! Philips's management wants to use your money to grow the business. In return you get a share of Philips.

What can you expect buying and holding a share of Philips?

First you should know what it really means to hold a share of Philips. And how you can make/lose money.

Speculation

The Price per Share of Philips is €18.90. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Philips.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Philips, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is €13.31. Based on the TTM, the Book Value Change Per Share is €-1.35 per quarter. Based on the YOY, the Book Value Change Per Share is €-0.58 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is €0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Philips.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 % of Price per Share% of Price per Share% of Price per Share% of Price per Share% of Price per Share
Usd Eps-0.55-2.9%-0.55-2.9%-1.89-10.0%0.784.1%0.955.0%
Usd Book Value Change Per Share-1.44-7.6%-1.44-7.6%-0.61-3.2%0.241.3%0.201.1%
Usd Dividend Per Share0.000.0%0.000.0%0.482.6%0.301.6%0.341.8%
Usd Total Gains Per Share-1.43-7.6%-1.43-7.6%-0.13-0.7%0.552.9%0.542.8%
Usd Price Per Share22.45-22.45-14.91-33.04-31.33-
Price to Earnings Ratio-41.01--41.01--7.89-6.41-19.37-
Price-to-Total Gains Ratio-15.67--15.67--114.69--33.13-83.85-
Price to Book Ratio1.58-1.58-0.96-2.31-2.30-
Price-to-Total Gains Ratio-15.67--15.67--114.69--33.13-83.85-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share20.115617
Number of shares49
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.30
Usd Book Value Change Per Share-1.440.24
Usd Total Gains Per Share-1.430.55
Gains per Quarter (49 shares)-70.2126.90
Gains per Year (49 shares)-280.85107.59
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-281-291604898
21-563-57211996206
31-844-853179144314
42-1125-1134239192422
52-1407-1415299239530
63-1688-1696358287638
73-1969-1977418335746
84-2251-2258478383854
94-2532-2539537431962
105-2813-28205974791070

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%1.02.00.033.3%3.02.00.060.0%8.02.00.080.0%25.08.00.075.8%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%5.05.00.050.0%18.015.00.054.5%
Dividend per Share1.00.00.0100.0%3.00.00.0100.0%5.00.00.0100.0%10.00.00.0100.0%30.00.03.090.9%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.04.00.060.0%20.013.00.060.6%

Fundamentals of Philips

About Koninklijke Philips NV

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease. In addition, the company offers acute patient management solutions; emergency care solutions; sleep and respiratory care solutions; and electronic medical record and care management solutions. Further, it provides power toothbrushes, brush heads, and interdental cleaning and teeth whitening products; infant feeding, baby monitors, and digital parental solutions; and grooming and beauty products and solutions. The company has strategic partnership agreements with TriHealth, Northwell, and Atrium Health. The company was formerly known as Koninklijke Philips Electronics N.V. and changed its name to Koninklijke Philips N.V. in May 2013. Koninklijke Philips N.V. was founded in 1891 and is headquartered in Amsterdam, the Netherlands.

Fundamental data was last updated by Penke on 2024-04-13 14:18:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Koninklijke Philips NV.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Philips earns for each €1 of revenue.

  • Above 10% is considered healthy but always compare Philips to the Medical Devices industry mean.
  • A Net Profit Margin of -2.6% means that €-0.03 for each €1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Koninklijke Philips NV:

  • The MRQ is -2.6%. The company is making a loss. -1
  • The TTM is -2.6%. The company is making a loss. -1
Trends
Current periodCompared to+/- 
MRQ-2.6%TTM-2.6%0.0%
TTM-2.6%YOY-9.1%+6.5%
TTM-2.6%5Y0.8%-3.4%
5Y0.8%10Y3.0%-2.2%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-2.6%-11.2%+8.6%
TTM-2.6%-19.6%+17.0%
YOY-9.1%-14.4%+5.3%
5Y0.8%-21.3%+22.1%
10Y3.0%-24.8%+27.8%
1.1.2. Return on Assets

Shows how efficient Philips is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Philips to the Medical Devices industry mean.
  • -1.6% Return on Assets means that Philips generated €-0.02 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Koninklijke Philips NV:

  • The MRQ is -1.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.6%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1.6%TTM-1.6%0.0%
TTM-1.6%YOY-5.3%+3.7%
TTM-1.6%5Y0.7%-2.3%
5Y0.7%10Y2.2%-1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.6%-4.0%+2.4%
TTM-1.6%-4.5%+2.9%
YOY-5.3%-4.8%-0.5%
5Y0.7%-4.0%+4.7%
10Y2.2%-5.2%+7.4%
1.1.3. Return on Equity

Shows how efficient Philips is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Philips to the Medical Devices industry mean.
  • -3.9% Return on Equity means Philips generated €-0.04 for each €1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Koninklijke Philips NV:

  • The MRQ is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -3.9%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.9%TTM-3.9%0.0%
TTM-3.9%YOY-12.2%+8.3%
TTM-3.9%5Y1.5%-5.4%
5Y1.5%10Y5.1%-3.6%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.9%-3.9%+0.0%
TTM-3.9%-5.6%+1.7%
YOY-12.2%-5.9%-6.3%
5Y1.5%-6.1%+7.6%
10Y5.1%-7.1%+12.2%

1.2. Operating Efficiency of Koninklijke Philips NV.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Philips is operating .

  • Measures how much profit Philips makes for each €1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Philips to the Medical Devices industry mean.
  • An Operating Margin of 0.0% means the company generated €0.00  for each €1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Koninklijke Philips NV:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.7%+0.7%
TTM-5Y3.8%-3.8%
5Y3.8%10Y5.3%-1.5%
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ--22.8%+22.8%
TTM--17.1%+17.1%
YOY-0.7%-13.4%+12.7%
5Y3.8%-19.2%+23.0%
10Y5.3%-24.0%+29.3%
1.2.2. Operating Ratio

Measures how efficient Philips is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Medical Devices industry mean).
  • An Operation Ratio of 1.60 means that the operating costs are €1.60 for each €1 in net sales.

Let's take a look of the Operating Ratio trends of Koninklijke Philips NV:

  • The MRQ is 1.599. The company is inefficient in keeping operating costs low. -1
  • The TTM is 1.599. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ1.599TTM1.5990.000
TTM1.599YOY1.010+0.590
TTM1.5995Y1.083+0.517
5Y1.08310Y1.009+0.073
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.5991.428+0.171
TTM1.5991.426+0.173
YOY1.0101.503-0.493
5Y1.0831.440-0.357
10Y1.0091.371-0.362

1.3. Liquidity of Koninklijke Philips NV.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Philips is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Medical Devices industry mean).
  • A Current Ratio of 1.20 means the company has €1.20 in assets for each €1 in short-term debts.

Let's take a look of the Current Ratio trends of Koninklijke Philips NV:

  • The MRQ is 1.200. The company is just able to pay all its short-term debts.
  • The TTM is 1.200. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.200TTM1.2000.000
TTM1.200YOY1.293-0.093
TTM1.2005Y1.338-0.139
5Y1.33810Y1.332+0.006
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.2002.787-1.587
TTM1.2002.763-1.563
YOY1.2933.488-2.195
5Y1.3383.617-2.279
10Y1.3323.514-2.182
1.3.2. Quick Ratio

Measures if Philips is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Philips to the Medical Devices industry mean.
  • A Quick Ratio of 0.45 means the company can pay off €0.45 for each €1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Koninklijke Philips NV:

  • The MRQ is 0.451. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.451. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.451TTM0.4510.000
TTM0.451YOY0.697-0.246
TTM0.4515Y0.770-0.319
5Y0.77010Y0.777-0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4511.539-1.088
TTM0.4511.660-1.209
YOY0.6972.139-1.442
5Y0.7702.300-1.530
10Y0.7772.255-1.478

1.4. Solvency of Koninklijke Philips NV.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Philips assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Philips to Medical Devices industry mean.
  • A Debt to Asset Ratio of 0.59 means that Philips assets are financed with 59.0% credit (debt) and the remaining percentage (100% - 59.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Koninklijke Philips NV:

  • The MRQ is 0.590. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.590. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.590TTM0.5900.000
TTM0.590YOY0.567+0.023
TTM0.5905Y0.558+0.031
5Y0.55810Y0.567-0.008
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ0.5900.389+0.201
TTM0.5900.386+0.204
YOY0.5670.338+0.229
5Y0.5580.442+0.116
10Y0.5670.460+0.107
1.4.2. Debt to Equity Ratio

Measures if Philips is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Philips to the Medical Devices industry mean.
  • A Debt to Equity ratio of 144.2% means that company has €1.44 debt for each €1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Koninklijke Philips NV:

  • The MRQ is 1.442. The company is able to pay all its debts with equity. +1
  • The TTM is 1.442. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.442TTM1.4420.000
TTM1.442YOY1.314+0.128
TTM1.4425Y1.274+0.168
5Y1.27410Y1.336-0.063
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
MRQ1.4420.559+0.883
TTM1.4420.560+0.882
YOY1.3140.478+0.836
5Y1.2740.624+0.650
10Y1.3360.674+0.662

2. Market Valuation of Koninklijke Philips NV

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every €1 in earnings Philips generates.

  • Above 15 is considered overpriced but always compare Philips to the Medical Devices industry mean.
  • A PE ratio of -41.01 means the investor is paying €-41.01 for every €1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Koninklijke Philips NV:

  • The EOD is -36.752. Based on the earnings, the company is expensive. -2
  • The MRQ is -41.012. Based on the earnings, the company is expensive. -2
  • The TTM is -41.012. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-36.752MRQ-41.012+4.260
MRQ-41.012TTM-41.0120.000
TTM-41.012YOY-7.894-33.118
TTM-41.0125Y6.411-47.423
5Y6.41110Y19.373-12.963
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD-36.752-1.037-35.715
MRQ-41.012-1.578-39.434
TTM-41.012-2.041-38.971
YOY-7.894-2.971-4.923
5Y6.411-2.058+8.469
10Y19.373-1.463+20.836
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Koninklijke Philips NV:

  • The EOD is 11.479. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The MRQ is 12.809. Based on how much money comes from the company's main activities, the company is cheap. +2
  • The TTM is 12.809. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD11.479MRQ12.809-1.330
MRQ12.809TTM12.8090.000
TTM12.809YOY-12.966+25.775
TTM12.8095Y20.042-7.233
5Y20.04210Y35.469-15.427
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD11.479-1.007+12.486
MRQ12.809-1.544+14.353
TTM12.809-3.018+15.827
YOY-12.966-6.339-6.627
5Y20.042-4.928+24.970
10Y35.469-4.950+40.419
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Philips is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Medical Devices industry mean).
  • A PB ratio of 1.58 means the investor is paying €1.58 for each €1 in book value.

Let's take a look of the Price to Book Ratio trends of Koninklijke Philips NV:

  • The EOD is 1.420. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.585. Based on the equity, the company is underpriced. +1
  • The TTM is 1.585. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.420MRQ1.585-0.165
MRQ1.585TTM1.5850.000
TTM1.585YOY0.956+0.629
TTM1.5855Y2.313-0.729
5Y2.31310Y2.301+0.012
Compared to industry (Medical Devices)
PeriodCompanyIndustry (mean)+/- 
EOD1.4201.987-0.567
MRQ1.5852.379-0.794
TTM1.5852.444-0.859
YOY0.9563.215-2.259
5Y2.3133.833-1.520
10Y2.3014.163-1.862
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Koninklijke Philips NV compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---1.348-1.3480%-0.577-57%0.229-688%0.188-816%
Book Value Per Share--13.30613.3060%14.655-9%13.721-3%12.946+3%
Current Ratio--1.2001.2000%1.293-7%1.338-10%1.332-10%
Debt To Asset Ratio--0.5900.5900%0.567+4%0.558+6%0.567+4%
Debt To Equity Ratio--1.4421.4420%1.314+10%1.274+13%1.336+8%
Dividend Per Share--0.0020.0020%0.455-100%0.286-99%0.315-99%
Eps---0.514-0.5140%-1.774+245%0.729-171%0.890-158%
Free Cash Flow Per Share--1.6461.6460%-1.080+166%0.888+85%0.811+103%
Free Cash Flow To Equity Per Share--0.7110.7110%-0.528+174%0.076+838%0.179+297%
Gross Profit Margin--1.0001.0000%3.849-74%-1.400+240%-3.421+442%
Intrinsic Value_10Y_max--14.295--------
Intrinsic Value_10Y_min--0.295--------
Intrinsic Value_1Y_max--1.008--------
Intrinsic Value_1Y_min--0.380--------
Intrinsic Value_3Y_max--3.352--------
Intrinsic Value_3Y_min--0.844--------
Intrinsic Value_5Y_max--6.086--------
Intrinsic Value_5Y_min--0.980--------
Market Cap17126484836.160-12%19111510544.26019111510544.2600%12693267724.032+51%29435822184.059-35%28542771738.404-33%
Net Profit Margin---0.026-0.0260%-0.091+254%0.008-421%0.030-186%
Operating Margin----0%-0.0070%0.038-100%0.053-100%
Operating Ratio--1.5991.5990%1.010+58%1.083+48%1.009+58%
Pb Ratio1.420-12%1.5851.5850%0.956+66%2.313-31%2.301-31%
Pe Ratio-36.752+10%-41.012-41.0120%-7.894-81%6.411-740%19.373-312%
Price Per Share18.895-12%21.08521.0850%14.004+51%31.031-32%29.433-28%
Price To Free Cash Flow Ratio11.479-12%12.80912.8090%-12.966+201%20.042-36%35.469-64%
Price To Total Gains Ratio-14.038+10%-15.665-15.6650%-114.688+632%-33.134+112%83.852-119%
Quick Ratio--0.4510.4510%0.697-35%0.770-41%0.777-42%
Return On Assets---0.016-0.0160%-0.053+233%0.007-312%0.022-170%
Return On Equity---0.039-0.0390%-0.122+215%0.015-361%0.051-176%
Total Gains Per Share---1.346-1.3460%-0.122-91%0.516-361%0.503-368%
Usd Book Value--12840140600.00012840140600.0000%14141081800.000-9%13700124480.000-6%13279820400.000-3%
Usd Book Value Change Per Share---1.435-1.4350%-0.614-57%0.244-688%0.200-816%
Usd Book Value Per Share--14.16614.1660%15.601-9%14.607-3%13.783+3%
Usd Dividend Per Share--0.0020.0020%0.484-100%0.305-99%0.335-99%
Usd Eps---0.547-0.5470%-1.889+245%0.776-171%0.948-158%
Usd Free Cash Flow--1588383200.0001588383200.0000%-1042243400.000+166%901077440.000+76%839117720.000+89%
Usd Free Cash Flow Per Share--1.7521.7520%-1.150+166%0.945+85%0.863+103%
Usd Free Cash Flow To Equity Per Share--0.7560.7560%-0.563+174%0.081+838%0.190+297%
Usd Market Cap18232855756.576-12%20346114125.41920346114125.4190%13513252819.005+51%31337376297.150-35%30386634792.705-33%
Usd Price Per Share20.116-12%22.44722.4470%14.909+51%33.035-32%31.335-28%
Usd Profit---496103600.000-496103600.0000%-1722522800.000+247%188008360.000-364%653451480.000-176%
Usd Revenue--19342717400.00019342717400.0000%18978624200.000+2%19624623480.000-1%21102607660.000-8%
Usd Total Gains Per Share---1.433-1.4330%-0.130-91%0.549-361%0.536-368%
 EOD+4 -4MRQTTM+0 -0YOY+17 -185Y+11 -2510Y+12 -24

3.2. Fundamental Score

Let's check the fundamental score of Koninklijke Philips NV based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-36.752
Price to Book Ratio (EOD)Between0-11.420
Net Profit Margin (MRQ)Greater than0-0.026
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.451
Current Ratio (MRQ)Greater than11.200
Debt to Asset Ratio (MRQ)Less than10.590
Debt to Equity Ratio (MRQ)Less than11.442
Return on Equity (MRQ)Greater than0.15-0.039
Return on Assets (MRQ)Greater than0.05-0.016
Total2/10 (20.0%)

3.3. Technical Score

Let's check the technical score of Koninklijke Philips NV based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5047.407
Ma 20Greater thanMa 5018.875
Ma 50Greater thanMa 10018.918
Ma 100Greater thanMa 20019.654
OpenGreater thanClose18.870
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in EUR. All numbers in thousands.

Summary
Total Assets29,406,000
Total Liabilities17,345,000
Total Stockholder Equity12,028,000
 As reported
Total Liabilities 17,345,000
Total Stockholder Equity+ 12,028,000
Total Assets = 29,406,000

Assets

Total Assets29,406,000
Total Current Assets9,940,000
Long-term Assets19,466,000
Total Current Assets
Cash And Cash Equivalents 1,869,000
Short-term Investments 3,000
Net Receivables 3,733,000
Inventory 3,491,000
Total Current Assets  (as reported)9,940,000
Total Current Assets  (calculated)9,096,000
+/- 844,000
Long-term Assets
Property Plant Equipment 2,483,000
Goodwill 9,876,000
Long Term Investments 1,000,000
Intangible Assets 3,190,000
Long-term Assets Other 94,000
Long-term Assets  (as reported)19,466,000
Long-term Assets  (calculated)16,643,000
+/- 2,823,000

Liabilities & Shareholders' Equity

Total Current Liabilities8,285,000
Long-term Liabilities9,060,000
Total Stockholder Equity12,028,000
Total Current Liabilities
Short Long Term Debt 654,000
Accounts payable 1,917,000
Other Current Liabilities 147,000
Total Current Liabilities  (as reported)8,285,000
Total Current Liabilities  (calculated)2,718,000
+/- 5,567,000
Long-term Liabilities
Long term Debt 6,095,000
Capital Lease Obligations Min Short Term Debt864,000
Long-term Liabilities Other 57,000
Long-term Liabilities  (as reported)9,060,000
Long-term Liabilities  (calculated)7,016,000
+/- 2,044,000
Total Stockholder Equity
Total Stockholder Equity (as reported)12,028,000
Total Stockholder Equity (calculated)0
+/- 12,028,000
Other
Capital Stock183,000
Common Stock Shares Outstanding 906,403
Net Debt 4,880,000
Net Invested Capital 18,777,000
Net Working Capital 1,655,000



Balance Sheet

Currency in EUR. All numbers in thousands.

 Trend2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-312013-12-312012-12-312011-12-312010-12-312009-12-312008-12-312007-12-312006-12-312005-12-312004-12-312003-12-312002-12-312001-12-312000-12-311999-12-311998-12-311997-12-311996-12-311995-12-311994-12-311993-12-311992-12-311991-12-311990-12-311989-12-311988-12-311987-12-31
> Total Assets 
21,736,405
22,540,011
24,275,352
22,331,080
21,801,865
22,220,214
21,353,996
22,606,590
25,355,030
25,403,311
26,672,701
27,994,533
29,582,147
38,647,933
38,520,891
32,318,072
28,949,540
30,700,029
33,834,879
38,496,714
36,399,807
31,790,000
30,527,000
32,269,000
28,966,000
29,079,000
26,559,000
28,352,000
30,976,000
32,303,000
25,315,000
26,019,000
26,983,000
27,713,000
30,961,000
30,688,000
29,406,000
29,406,00030,688,00030,961,00027,713,00026,983,00026,019,00025,315,00032,303,00030,976,00028,352,00026,559,00029,079,00028,966,00032,269,00030,527,00031,790,00036,399,80738,496,71433,834,87930,700,02928,949,54032,318,07238,520,89138,647,93329,582,14727,994,53326,672,70125,403,31125,355,03022,606,59021,353,99622,220,21421,801,86522,331,08024,275,35222,540,01121,736,405
   > Total Current Assets 
12,081,507
12,701,099
13,452,392
12,344,305
11,755,029
12,748,242
12,734,696
14,044,749
13,935,042
14,931,686
14,209,077
16,177,518
14,916,788
13,322,027
11,484,112
11,061,123
11,483,262
13,312,911
15,094,574
14,962,104
17,859,369
12,029,000
11,909,000
14,597,000
12,480,000
12,528,000
11,474,000
12,406,000
12,693,000
14,075,000
10,117,000
9,572,000
9,439,000
11,227,000
10,347,000
10,259,000
9,940,000
9,940,00010,259,00010,347,00011,227,0009,439,0009,572,00010,117,00014,075,00012,693,00012,406,00011,474,00012,528,00012,480,00014,597,00011,909,00012,029,00017,859,36914,962,10415,094,57413,312,91111,483,26211,061,12311,484,11213,322,02714,916,78816,177,51814,209,07714,931,68613,935,04214,044,74912,734,69612,748,24211,755,02912,344,30513,452,39212,701,09912,081,507
       Cash And Cash Equivalents 
801,778
609,479
64,870
64,072
846,401
754,229
1,071,329
1,326,672
1,291,063
989,072
1,692,726
6,516,028
2,337,394
1,092,423
891,261
1,859,244
3,066,544
4,345,673
5,288,758
6,022,878
8,782,565
3,620,000
4,386,000
5,833,000
3,147,000
3,834,000
2,465,000
1,873,000
1,766,000
2,334,000
1,939,000
1,688,000
1,425,000
3,226,000
2,303,000
1,172,000
1,869,000
1,869,0001,172,0002,303,0003,226,0001,425,0001,688,0001,939,0002,334,0001,766,0001,873,0002,465,0003,834,0003,147,0005,833,0004,386,0003,620,0008,782,5656,022,8785,288,7584,345,6733,066,5441,859,244891,2611,092,4232,337,3946,516,0281,692,726989,0721,291,0631,326,6721,071,329754,229846,40164,07264,870609,479801,778
       Short-term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
1,527,455
111,798
130,374
0
0
0
0
0
0
0
0
0
0
0
10,000
125,000
12,000
101,000
2,000
436,000
1,000
0
2,000
11,000
3,000
3,00011,0002,00001,000436,0002,000101,00012,000125,00010,00000000000000130,374111,7981,527,455000000000000
       Net Receivables 
5,411,597
6,063,963
7,099,916
6,248,995
6,352,602
7,217,974
7,196,925
7,812,107
6,019,657
6,537,835
6,622,721
5,075,032
6,098,889
6,518,338
5,821,854
5,072,659
4,620,461
4,524,191
5,151,135
4,772,689
4,676,948
4,289,000
3,983,000
4,434,000
4,577,000
4,682,000
4,748,000
4,863,000
5,096,000
5,481,000
4,018,000
4,182,000
4,712,000
4,306,000
3,967,000
4,337,000
3,733,000
3,733,0004,337,0003,967,0004,306,0004,712,0004,182,0004,018,0005,481,0005,096,0004,863,0004,748,0004,682,0004,577,0004,434,0003,983,0004,289,0004,676,9484,772,6895,151,1354,524,1914,620,4615,072,6595,821,8546,518,3386,098,8895,075,0326,622,7216,537,8356,019,6577,812,1077,196,9257,217,9746,352,6026,248,9957,099,9166,063,9635,411,597
       Inventory 
5,263,131
5,381,959
5,669,318
5,005,063
4,556,026
4,776,039
4,466,531
4,905,970
5,884,733
4,966,248
5,124,540
4,250,510
4,579,384
5,293,887
4,297,832
3,525,036
3,198,353
3,227,350
3,477,713
2,879,980
3,207,814
3,371,000
2,913,000
3,865,000
3,625,000
3,495,000
3,240,000
3,314,000
3,463,000
3,392,000
2,353,000
2,674,000
2,773,000
2,993,000
3,450,000
4,049,000
3,491,000
3,491,0004,049,0003,450,0002,993,0002,773,0002,674,0002,353,0003,392,0003,463,0003,314,0003,240,0003,495,0003,625,0003,865,0002,913,0003,371,0003,207,8142,879,9803,477,7133,227,3503,198,3533,525,0364,297,8325,293,8874,579,3844,250,5105,124,5404,966,2485,884,7334,905,9704,466,5314,776,0394,556,0265,005,0635,669,3185,381,9595,263,131
       Other Current Assets 
605,001
645,698
618,289
1,026,174
0
0
-90
0
739,589
2,438,531
909
335,948
994
-1,065
342,793
953
597,905
1,215,697
1,176,968
490,983
1,192,042
749,000
627,000
465,000
351,000
337,000
354,000
411,000
444,000
486,000
392,000
469,000
477,000
424,000
493,000
490,000
0
0490,000493,000424,000477,000469,000392,000486,000444,000411,000354,000337,000351,000465,000627,000749,0001,192,042490,9831,176,9681,215,697597,905953342,793-1,065994335,9489092,438,531739,5890-90001,026,174618,289645,698605,001
   > Long-term Assets 
9,654,898
9,838,912
10,822,959
9,986,775
10,046,836
9,471,972
8,619,300
8,561,841
11,419,988
10,471,625
12,463,624
11,817,015
14,665,359
25,325,906
27,036,779
21,256,949
17,466,278
17,387,118
18,740,305
23,534,609
18,540,438
19,761,000
18,618,000
17,672,000
16,486,000
16,551,000
15,085,000
15,946,000
18,283,000
18,228,000
15,198,000
16,447,000
17,544,000
16,486,000
20,613,000
20,429,000
19,466,000
19,466,00020,429,00020,613,00016,486,00017,544,00016,447,00015,198,00018,228,00018,283,00015,946,00015,085,00016,551,00016,486,00017,672,00018,618,00019,761,00018,540,43823,534,60918,740,30517,387,11817,466,27821,256,94927,036,77925,325,90614,665,35911,817,01512,463,62410,471,62511,419,9888,561,8418,619,3009,471,97210,046,8369,986,77510,822,9599,838,9129,654,898
       Property Plant Equipment 
8,046,657
7,914,918
8,210,881
7,224,963
7,169,716
6,594,746
6,007,027
6,085,615
6,843,788
7,199,895
7,225,447
6,537,344
7,354,046
9,066,261
7,731,377
6,141,892
4,870,580
4,993,356
4,889,399
3,098,952
3,185,180
3,496,000
3,252,000
3,265,000
3,014,000
2,959,000
2,780,000
2,095,000
2,322,000
2,155,000
1,591,000
1,712,000
2,866,000
2,682,000
2,699,000
2,638,000
2,483,000
2,483,0002,638,0002,699,0002,682,0002,866,0001,712,0001,591,0002,155,0002,322,0002,095,0002,780,0002,959,0003,014,0003,265,0003,252,0003,496,0003,185,1803,098,9524,889,3994,993,3564,870,5806,141,8927,731,3779,066,2617,354,0466,537,3447,225,4477,199,8956,843,7886,085,6156,007,0276,594,7467,169,7167,224,9638,210,8817,914,9188,046,657
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
3,820,273
4,141,283
7,280,000
7,362,000
8,035,000
7,016,000
6,948,000
6,504,000
7,158,000
8,523,000
8,898,000
7,731,000
8,503,000
8,654,000
8,014,000
10,637,000
10,238,000
9,876,000
9,876,00010,238,00010,637,0008,014,0008,654,0008,503,0007,731,0008,898,0008,523,0007,158,0006,504,0006,948,0007,016,0008,035,0007,362,0007,280,0004,141,2833,820,2730000000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
619,000
670,000
391,000
616,000
558,000
481,000
670,000
1,056,000
1,197,000
1,000,000
1,000,0001,197,0001,056,000670,000481,000558,000616,000391,000670,000619,000000000000000000000000000000
       Intangible Assets 
12,596
20,036
275,488
486,086
527,385
801,979
1,170,002
1,075,836
1,349,790
1,460,708
1,602,726
550,818
2,830,314
4,438,901
7,281,813
4,938,291
3,758,144
2,804,659
4,044,245
1,914,683
2,157,061
4,477,000
4,161,000
4,198,000
3,996,000
3,731,000
3,262,000
3,368,000
3,693,000
3,552,000
3,322,000
3,589,000
3,466,000
2,997,000
3,650,000
3,526,000
3,190,000
3,190,0003,526,0003,650,0002,997,0003,466,0003,589,0003,322,0003,552,0003,693,0003,368,0003,262,0003,731,0003,996,0004,198,0004,161,0004,477,0002,157,0611,914,6834,044,2452,804,6593,758,1444,938,2917,281,8134,438,9012,830,314550,8181,602,7261,460,7081,349,7901,075,8361,170,002801,979527,385486,086275,48820,03612,596
       Long-term Assets Other 
1,595,645
1,903,958
2,336,591
2,275,725
2,349,736
2,075,247
1,442,271
1,400,389
3,226,410
1,811,021
3,635,451
4,728,852
4,480,999
11,820,743
12,023,589
10,176,767
8,837,554
9,589,102
9,806,661
13,556,589
9,056,913
3,284,000
2,319,000
642,000
544,000
270,000
207,000
246,000
317,000
306,000
227,000
211,000
226,000
303,000
355,000
381,000
94,000
94,000381,000355,000303,000226,000211,000227,000306,000317,000246,000207,000270,000544,000642,0002,319,0003,284,0009,056,91313,556,5899,806,6619,589,1028,837,55410,176,76712,023,58911,820,7434,480,9994,728,8523,635,4511,811,0213,226,4101,400,3891,442,2712,075,2472,349,7362,275,7252,336,5911,903,9581,595,645
> Total Liabilities 
14,983,775
15,485,709
15,838,015
16,610,570
16,014,751
18,093,801
15,328,955
15,825,224
18,533,547
18,266,890
16,864,529
13,634,033
14,447,719
16,381,025
19,833,640
18,207,445
16,033,848
15,568,736
16,849,895
15,368,984
14,639,895
16,197,000
15,883,000
17,177,000
16,577,000
17,905,000
15,332,000
17,384,000
19,196,000
18,795,000
13,292,000
13,902,000
14,358,000
15,812,000
16,487,000
17,405,000
17,345,000
17,345,00017,405,00016,487,00015,812,00014,358,00013,902,00013,292,00018,795,00019,196,00017,384,00015,332,00017,905,00016,577,00017,177,00015,883,00016,197,00014,639,89515,368,98416,849,89515,568,73616,033,84818,207,44519,833,64016,381,02514,447,71913,634,03316,864,52918,266,89018,533,54715,825,22415,328,95518,093,80116,014,75116,610,57015,838,01515,485,70914,983,775
   > Total Current Liabilities 
8,093,202
8,225,052
9,448,048
8,590,544
8,607,454
10,291,826
7,596,903
8,646,404
11,287,014
10,411,364
10,762,717
8,855,727
9,634,794
11,562,012
10,939,016
9,134,217
9,225,041
9,167,887
10,367,282
9,130,165
9,648,133
8,913,000
8,050,000
10,758,000
9,343,000
9,955,000
8,476,000
9,227,000
10,068,000
10,473,000
6,865,000
7,943,000
6,945,000
7,736,000
7,450,000
7,934,000
8,285,000
8,285,0007,934,0007,450,0007,736,0006,945,0007,943,0006,865,00010,473,00010,068,0009,227,0008,476,0009,955,0009,343,00010,758,0008,050,0008,913,0009,648,1339,130,16510,367,2829,167,8879,225,0419,134,21710,939,01611,562,0129,634,7948,855,72710,762,71710,411,36411,287,0148,646,4047,596,90310,291,8268,607,4548,590,5449,448,0488,225,0528,093,202
       Short-term Debt 
7,244,419
7,304,241
6,430,574
1,417,904
1,221,525
4,862,518
1,432,054
1,453,068
2,160,273
2,563,873
974,544
796,384
578,386
1,748,303
1,273,390
617,525
1,680,962
960,459
1,165,992
863,009
2,348,419
722,000
627,000
1,840,000
582,000
809,000
592,000
392,000
1,665,000
1,585,000
672,000
1,394,000
508,000
1,229,000
506,000
931,000
0
0931,000506,0001,229,000508,0001,394,000672,0001,585,0001,665,000392,000592,000809,000582,0001,840,000627,000722,0002,348,419863,0091,165,992960,4591,680,962617,5251,273,3901,748,303578,386796,384974,5442,563,8732,160,2731,453,0681,432,0544,862,5181,221,5251,417,9046,430,5747,304,2417,244,419
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
94,000
84,000
1,585,000
623,000
1,306,000
110,000
1,229,000
506,000
931,000
654,000
654,000931,000506,0001,229,000110,0001,306,000623,0001,585,00084,00094,000000000000000000000000000000
       Accounts payable 
0
0
0
0
0
0
0
197,749
3,113,479
2,900,527
3,304,542
2,931,445
3,642,240
4,266,413
3,248,100
3,230,568
3,199,147
3,496,603
3,853,431
3,449,763
3,087,787
2,992,000
2,870,000
3,691,000
3,346,000
2,839,000
2,458,000
2,499,000
2,673,000
2,848,000
2,090,000
2,303,000
2,089,000
2,119,000
1,872,000
1,968,000
1,917,000
1,917,0001,968,0001,872,0002,119,0002,089,0002,303,0002,090,0002,848,0002,673,0002,499,0002,458,0002,839,0003,346,0003,691,0002,870,0002,992,0003,087,7873,449,7633,853,4313,496,6033,199,1473,230,5683,248,1004,266,4133,642,2402,931,4453,304,5422,900,5273,113,479197,7490000000
       Other Current Liabilities 
848,783
920,811
3,017,475
7,172,640
7,385,929
5,429,307
6,164,849
6,995,587
6,013,262
4,946,965
2,316,361
2,241,643
1,850,437
1,835,612
2,273,670
1,968,836
1,596,000
1,406,018
1,719,015
1,481,284
1,222,906
522,000
703,000
1,318,000
1,439,000
5,999,000
5,186,000
6,024,000
5,355,000
5,589,000
3,731,000
3,368,000
3,178,000
3,149,000
3,581,000
3,339,000
147,000
147,0003,339,0003,581,0003,149,0003,178,0003,368,0003,731,0005,589,0005,355,0006,024,0005,186,0005,999,0001,439,0001,318,000703,000522,0001,222,9061,481,2841,719,0151,406,0181,596,0001,968,8362,273,6701,835,6121,850,4372,241,6432,316,3614,946,9656,013,2626,995,5876,164,8495,429,3077,385,9297,172,6403,017,475920,811848,783
   > Long-term Liabilities 
6,890,573
7,260,658
6,389,966
8,020,025
7,407,297
7,801,976
7,732,052
7,178,821
7,246,534
7,855,526
6,101,812
4,778,307
4,812,925
4,819,013
8,894,624
9,073,227
6,808,807
6,400,849
6,482,612
6,238,819
4,991,762
7,284,000
7,833,000
6,419,000
7,234,000
7,950,000
6,856,000
8,157,000
9,128,000
8,322,000
6,427,000
5,959,000
7,413,000
8,076,000
9,037,000
9,471,000
9,060,000
9,060,0009,471,0009,037,0008,076,0007,413,0005,959,0006,427,0008,322,0009,128,0008,157,0006,856,0007,950,0007,234,0006,419,0007,833,0007,284,0004,991,7626,238,8196,482,6126,400,8496,808,8079,073,2278,894,6244,819,0134,812,9254,778,3076,101,8127,855,5267,246,5347,178,8217,732,0527,801,9767,407,2978,020,0256,389,9667,260,6586,890,573
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,095,000
4,021,000
3,468,000
3,239,000
4,877,000
0
0
0
0
00004,877,0003,239,0003,468,0004,021,0004,095,0000000000000000000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
4,996,000
5,142,000
4,323,000
2,382,000
2,532,000
2,474,000
2,372,000
2,564,000
2,201,000
0
02,201,0002,564,0002,372,0002,474,0002,532,0002,382,0004,323,0005,142,0004,996,000000000000000000000000000000
       Deferred Long Term Liability 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
889,000
501,000
537,000
586,000
620,000
592,000
621,000
598,000
393,000
0
0393,000598,000621,000592,000620,000586,000537,000501,000889,000000000000000000000000000000
> Total Stockholder Equity
6,752,630
7,054,301
8,437,337
5,720,510
5,787,114
4,126,413
6,025,041
6,781,365
6,821,483
6,437,402
8,730,900
14,120,050
14,800,514
21,796,293
18,484,948
13,931,468
12,741,005
14,848,761
16,653,170
22,996,649
21,718,074
15,593,000
14,595,000
15,046,000
12,355,000
11,140,000
11,214,000
10,867,000
11,662,000
12,601,000
11,999,000
12,088,000
12,597,000
11,870,000
14,438,000
13,249,000
12,028,000
12,028,00013,249,00014,438,00011,870,00012,597,00012,088,00011,999,00012,601,00011,662,00010,867,00011,214,00011,140,00012,355,00015,046,00014,595,00015,593,00021,718,07422,996,64916,653,17014,848,76112,741,00513,931,46818,484,94821,796,29314,800,51414,120,0508,730,9006,437,4026,821,4836,781,3656,025,0414,126,4135,787,1145,720,5108,437,3377,054,3016,752,630
   Common Stock
0
0
0
0
0
0
0
0
0
1,626,223
1,637,271
1,662,687
339,876
264,056
262,995
263,020
262,824
262,614
262,580
228,065
228,395
194,000
194,000
197,000
202,000
191,000
188,000
187,000
186,000
186,000
188,000
185,000
179,000
182,000
177,000
178,000
0
0178,000177,000182,000179,000185,000188,000186,000186,000187,000188,000191,000202,000197,000194,000194,000228,395228,065262,580262,614262,824263,020262,995264,056339,8761,662,6871,637,2711,626,223000000000
   Retained Earnings 
3,757,580
3,883,693
6,235,879
2,744,444
3,306,036
317,531
786,155
800,537
3,460,461
3,128,712
5,324,540
10,643,755
1,804,723
9,628,444
19,505,458
16,753,213
16,940,630
19,331,642
21,693,701
22,085,148
25,599,412
18,439,000
15,947,000
15,416,000
12,917,000
10,713,000
10,415,000
8,790,000
8,040,000
8,233,000
8,596,000
8,266,000
8,296,000
7,827,000
9,344,000
6,832,000
0
06,832,0009,344,0007,827,0008,296,0008,266,0008,596,0008,233,0008,040,0008,790,00010,415,00010,713,00012,917,00015,416,00015,947,00018,439,00025,599,41222,085,14821,693,70119,331,64216,940,63016,753,21319,505,4589,628,4441,804,72310,643,7555,324,5403,128,7123,460,461800,537786,155317,5313,306,0362,744,4446,235,8793,883,6933,757,580
   Accumulated Other Comprehensive Income 
-8,953,275
-9,051,162
-8,905,498
-7,713,968
-7,897,476
-8,747,783
-1,388,229
-1,367,119
-9,888,323
-9,603,877
-10,156,353
-10,040,924
11,020,137
11,897,405
-10,369,194
-1,790,631
-3,279,344
-3,604,304
-2,467,918
1,607,060
-1,890,258
-3,240,000
0
0
52,000
35,000
-467,000
256,000
1,130,000
1,280,000
11,811,000
11,903,000
652,000
-340,000
748,000
1,488,000
0
01,488,000748,000-340,000652,00011,903,00011,811,0001,280,0001,130,000256,000-467,00035,00052,00000-3,240,000-1,890,2581,607,060-2,467,918-3,604,304-3,279,344-1,790,631-10,369,19411,897,40511,020,137-10,040,924-10,156,353-9,603,877-9,888,323-1,367,119-1,388,229-8,747,783-7,897,476-7,713,968-8,905,498-9,051,162-8,953,275
   Capital Surplus 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,669,000
3,083,000
3,311,000
3,487,000
3,671,000
4,400,000
0
0
0
0004,400,0003,671,0003,487,0003,311,0003,083,0002,669,0000000000000000000000000000000
   Treasury Stock000-199,000-201,000-399,000-481,000-181,000-363,0000000000000000000000000000000
   Other Stockholders Equity 
11,948,325
12,221,770
11,106,956
10,690,035
10,378,553
12,556,664
6,627,114
7,347,947
13,249,345
11,286,343
11,925,443
11,854,532
23,658,165
23,159,160
9,085,688
-1,294,133
-1,183,105
-1,141,191
-2,835,193
-923,624
-2,219,475
-15,344,000
-1,546,000
-567,000
-816,000
201,000
1,078,000
2,693,000
3,264,000
2,902,000
385,000
548,000
11,766,000
12,028,000
13,513,000
4,751,000
0
04,751,00013,513,00012,028,00011,766,000548,000385,0002,902,0003,264,0002,693,0001,078,000201,000-816,000-567,000-1,546,000-15,344,000-2,219,475-923,624-2,835,193-1,141,191-1,183,105-1,294,1339,085,68823,159,16023,658,16511,854,53211,925,44311,286,34313,249,3457,347,9476,627,11412,556,66410,378,55310,690,03511,106,95612,221,77011,948,325



Balance Sheet

Currency in EUR. All numbers in thousands.